EARLY ALZHEIMER'S DISEASE
Clinical trials for EARLY ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for EARLY ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could this drug slow Alzheimer's brain damage?
Disease control Recruiting nowThis study tests an experimental drug called MK-2214 in 340 people with early Alzheimer's disease. The goal is to see if it can slow the buildup of a harmful protein called tau in the brain, which damages brain cells. Participants will receive either the drug or a placebo, and re…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could one stem cell infusion slow Alzheimer's decline?
Disease control Recruiting nowThis study tests whether adding a single infusion of human stem cells to standard antibody therapy can slow memory and thinking decline in people with mild Alzheimer's or mild cognitive impairment. Ten participants aged 55-90 who are already on antibody treatment will receive one…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Bernard (Barry) Baumel • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New pill aims to slow Alzheimer's: phase 2 trial underway
Disease control Recruiting nowThis Phase 2 trial tests whether TTYP01 tablets can slow cognitive decline in people with early Alzheimer's disease. About 180 participants aged 60-85 with mild cognitive impairment or mild dementia will receive either a low dose, high dose, or placebo for 78 weeks. Researchers w…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Shanghai Auzone Biological Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC